Guangzhou University of Chinese Medicine
Guangzhou University of Chinese Medicine is based on the Guangdong Chinese Medicine Specialized School established in 1924. In 1956, it was approved by the State Council to establish Guangzhou Chinese Medicine College, becoming one of the first four higher education institutions for Chinese medicine in New China. In 1995, it was renamed Guangzhou University of Chinese Medicine. Originally under the direct administration of the Ministry of Health, it was transferred to the management of the Guangdong Provincial People's Government in 2000. In 2017, it was selected as a national "Double First-Class" discipline construction university, and in 2018, it was upgraded to a key construction university for high-level universities in Guangdong Province. In 2020, it became a jointly established institution by the Guangdong Provincial People's Government, the Ministry of Education, and the National Administration of Traditional Chinese Medicine. The university adheres to the comprehensive leadership of the Party, maintains the socialist direction of running schools, and upholds the president's responsibility system under the leadership of the Party Committee. It is loyal to the Party's educational cause, implements the fundamental task of fostering virtue and nurturing people, and upholds the school motto of "Cultivating Virtue and Broad Learning, Sincerely Benefiting the World" and the university spirit of "Upholding Virtue and Ambition, Harmonious and Inclusive, Drawing from the Past and Seeking Innovation, Diligent Learning and Professionalism," aiming to cultivate socialist builders and successors with all-round development in morality, intelligence, physical fitness, aesthetics, and labor.
21
2022/01
Shanghai Kaibao Pharmaceutical Co., Ltd.
The Phlegm-Heat Clearing Injection developed and produced by Shanghai Kaibao Pharmaceutical Co., Ltd. has successively won several honors, including the "National Modern Traditional Chinese Medicine High-Tech Industrialization Demonstration Project" from the National Development and Reform Commission; key new product for combating SARS in Shanghai; "Shanghai Excellent Products in the Pharmaceutical Industry"; Shanghai High-Tech Achievement (A) Level Transformation Project; National Science and Technology Innovation Fund Support Project; Third Prize for Scientific and Technological Progress in Shanghai; "Influenza Prevention and Treatment Traditional Chinese Medicine Reserve Directory" from the National Development and Reform Commission; "Influenza Prevention and Treatment Reserve Drugs"; Shanghai Brand Product; Shanghai Patent New Product; Top 100 Projects for Transformation of High-Tech Achievements in Shanghai and Top Ten Independent Innovation Projects; "Shanghai Famous Brand Product"; listed by the Ministry of Health as a medication for the "Avian Influenza Diagnosis and Treatment Plan"; and in 2009, designated by the Ministry of Health and the State Administration of Traditional Chinese Medicine as a clinical designated medication in the "Clinical Technical Guidelines for Traditional Chinese Medicine in the Prevention and Treatment of Hand, Foot, and Mouth Disease" and the "H1N1 Influenza Diagnosis and Treatment Plan (2009 Trial Version 2nd Edition)". The Phlegm-Heat Clearing Injection has gained wide recognition from doctors and patients, becoming a well-known product brand, and its market performance is leading among similar products.
19
2022/01
Shanghai Chuangshi Industrial (Group) Co., Ltd.
Shanghai Chuangshi Industrial Co., Ltd. is highly focused – With years of effort and continuous growth, we have always adhered to the spirit of focus and professionalism, dedicated to the research and development of cold and hot materials, products, and technologies. We enhance people's quality of life through perfect product design and provide a source of power for the long-term and stable development of enterprises through our focus. We have successfully developed the medical device markets in North America, Europe, and Japan, as well as the daily gift market and home goods market, establishing stable partnerships with world-renowned companies and top brands.
25
2021/12
Beijing Zhongke Microneedle Technology Co., Ltd.
Zhongke Microneedle (Beijing) Technology Co., Ltd. has established a polymer microneedle drug delivery technology R&D platform and a pilot production platform that complies with GMP standards. The company is mainly engaged in the research and production of drugs, medical devices, cosmetics, and related research/production equipment based on microneedle transdermal drug delivery technology. It is the first domestic unit dedicated to building an internationally advanced and domestically first-class microneedle formulation R&D service platform, aiming to provide advanced microneedle transdermal drug delivery solutions for innovation in the pharmaceutical and medical beauty industries.
25
2021/12
Henan Lingrui Pharmaceutical Beijing Drug Research Institute
Zhengzhou Lingrui Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise jointly invested by Henan Lingrui Pharmaceutical Co., Ltd., a publicly listed company with strong financial strength; Honghui Pharmaceutical Co., Ltd., which has strong market development capabilities; Beijing Gaobo Pharmaceutical Chemical Technology Co., Ltd., which has leading research and development levels in China; and Zhengzhou Dongfang Pharmaceutical Co., Ltd.
23
2021/12
Beijing XinyiHuida Electromechanical
E-mail: xinyihuida@163.com
Mobile: +86-13911770565 Mr. Lin (General Manager)
Address: 415, 4th Floor, No.2 Jinguangnan Street, Jinguangnan Street, Xilu Street, Fangshan District, Beijing
Product Category
Copyright© Beijing XinyiHuida Electromechanical Equipment Co., Ltd